Bayer funds educational programs to improve clinician understanding of cardio-renal risk and recent advances in chronic kidney disease care for non-diabetic patients.
Bayer funds educational programs to improve early diagnosis, screening, and management of chronic kidney disease in type 2 diabetes, focusing on guideline-based practices and cardio-renal risk reduction.
Supports innovative research to discover and investigate new targets or biomarkers for kidney cancer, encouraging basic, translational, and clinical science that could lead to new treatments.
AACR-KidneyCAN Kidney Cancer Innovation and Discovery Grants support researchers studying druggable targets and biomarkers to advance new kidney cancer treatments, diagnosis, monitoring, and prognosis.
William and Sandra Bennett Clinical Scholars Program supports aspiring nephrology clinician educators in developing teaching skills and projects that address educational gaps and have impact beyond their institutions.